Health News

1 in 4 former NFL players may have CTE, new study says

  • Aug 25

'An exceptional moment': FDA approves drug to treat advanced pancreatic cancer

  • 2 days ago

US officials tie cyclospora outbreak involving iceberg lettuce to 3 more states

  • 16 hours ago

Congo begins vaccinations to fight the fastest-growing Ebola outbreak in history

  • 15 hours ago

These popular cereals now made without artificial colors, manufacturer says

  • 20 hours ago

'An exceptional moment': FDA approves drug to treat advanced pancreatic cancer

  • 2 days ago

An infant is one of the 2 measles-associated deaths in Pennsylvania

  • 1 day ago

Trump administration to end Medicare Part D subsidy program in 2027

  • Jul 29

Latest Videos

0:36

General Mills ditches artificial colors for cereal

  • 18 hours ago
0:25

FDA approves breakthrough pancreatic cancer treatment

  • 2 days ago
0:25

FDA approves breakthrough drug to treat advanced pancreatic cancer

  • 2 days ago
1:22

2 people die from measles in Pennsylvania, marking state's first deaths in 35 years

  • Aug 26
4:12

Study suggests at least 1 in 4 former NFL players may have CTE

  • Aug 25
6:31

How GLP-1 drugs affect the body and digestive system

  • Aug 24
4:53

E. coli and salmonella outbreak may be linked to alfalfa sprouts

  • Aug 22
1:19

More than 11,500 cyclosporiasis cases reported in 41 states: CDC

  • Aug 21
3:45

Senior gamers combat loneliness while representing USA in global competition

  • Aug 21
0:49

FDA and CDC tracking several foodborne illness outbreaks

  • Aug 21
Playlist ·  10 Videos

Latest Stories

From retirement to Rocket League: Senior gamers head to global esports competition

Eleven Ohio seniors, ages 64 to 76, have been selected to compete in LA.

  • Aug 22

Company recalls alfalfa sprouts after CDC says 55 sickened by salmonella, E. coli

At least four people have been hospitalized, health officials said.

  • Aug 21
4:11

Personalized cancer vaccine shows promise in melanoma trial

Dr. Jeffrey Farma explains how an mRNA-based vaccine could help prevent high-risk melanoma from returning or spreading.

  • Aug 20
1:02

Personalized mRNA cancer vaccine shows promise in melanoma trial

Merck and Moderna announced Wednesday that a personalized mRNA-based cancer vaccine succeeded in a large, late-stage trial among high-risk patients who had melanoma - a dangerous type of skin cancer.

  • Aug 19
2:18

Personalized mRNA-based cancer vaccine shows promise

Drugmakers Merck and Moderna announced Wednesday that a personalized mRNA-based cancer vaccine succeeded in a large late-stage trial involving high-risk melanoma patients.

  • Aug 19